Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic SyndromeMarie‐Agnès Dragon‐Durey, Véronique Frémeaux‐Bacchi, Patrick Niaudet et al.|Journal of the American Society of Nephrology|2010Cited by 296
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in childrenAditi Sinha, for the Indian HUS Registry, Ashima Gulati et al.|Kidney International|2013Cited by 216
Hemolytic uremic syndrome in a developing country: Consensus guidelinesMarie‐Agnès Dragon‐Durey, Arvind Bagga, Priyanka Khandelwal et al.|Pediatric Nephrology|2019Cited by 75
Effect of plasma exchange and immunosuppressive medications on antibody titers and outcome in anti-complement factor H antibody-associated hemolytic uremic syndromePriyanka Khandelwal, Arvind Bagga, Aarti Gupta et al.|Pediatric Nephrology|2014Cited by 43
Hemolytic uremic syndrome due to homozygous factor H deficiencySidharth Kumar Sethi, Arvind Bagga, Marie‐Agnès Dragon‐Durey et al.|Clinical and Experimental Nephrology|2009Cited by 10